Omeros

Omeros Kidney Drug Reports Good Results
Investopedia
Tue, 10/18/16 - 09:21 am
Omeros
OMS721
kidney disease
Omeros' Pipeline Is Largely Neglected
Seeking Alpha
Sun, 04/24/16 - 11:56 am
Omeros
OMS824
OMS721
Qmidria
FDA fast-tracks Omeros' kidney drug as company moves into Phase 3 tests
Bizjournals.com
Wed, 03/9/16 - 09:18 am
FDA
fast track
Omeros
OMS721
kidney disease
Omeros notches $13 million in sales of first drug
Bizjournals.com
Mon, 03/7/16 - 09:55 pm
Omeros
Omidria
post-surgical pain
Omeros CEO: For biotechs, better to be a jack of all trades than a master of one
Bizjournals.com
Mon, 11/30/15 - 11:07 pm
Omeros
What Lit a Fire Under These 3 Pharma Stocks
24/7 Wall St
Sun, 08/23/15 - 11:41 am
Aveo Pharmaceuticals
Omeros
Corbus Pharmaceuticals
Omeros Corporation: Another Biotech Bubble In The Making?
Yahoo/Benzinga
Wed, 08/19/15 - 09:26 am
Omeros
OMS721
Soliris
aHUS
Omeros reports 4Q loss
Yahoo/AP
Tue, 03/17/15 - 08:16 am
Omeros
earnings
Omeros suspends OMS824 trial in Huntington's Disease
Seeking Alpha
Tue, 10/21/14 - 09:14 am
Omeros
OMS824
Huntington's disease
FDA approves Omeros eye drug
Yahoo/Reuters
Mon, 06/2/14 - 10:49 am
FDA
Omeros
Omidria
cataracts
2nd Half Of 2014 Biotechnology Catalysts: Part 1
Seeking Alpha
Tue, 05/27/14 - 11:53 am
AcelRx
Anacor
BioDelivery Sciences
Eagle Pharmaceuticals
MannKind
Navidea Biopharmaceuticals
Orexigen
Omeros
EnteroMedics
Progenics
Trimel Pharmaceuticals
Morning Movers in Biotech: Medicines Co., Omeros Corporation, Opko Health, Inc. and VIVUS, Inc.
Motley Fool
Thu, 04/3/14 - 09:21 am
Medicines Company
Omeros
OPKO Health
Vivus
OMS721
Qsymia
Fibrocaps
Today's Biggest Biotech Stories: Dendreon, AbbVie, and Omeros
Motley Fool
Tue, 03/4/14 - 12:31 pm
Dendreon
AbbVie
Omeros
Provenge
prostate cancer
ABT-450
hepatitis C
OMS721
3 Under-the-Radar Biotech Stocks You Need to Watch in 2014
Motley Fool
Mon, 02/24/14 - 10:10 am
Nektar
Omeros
Spectrum Pharmaceuticals
Omeros Corp reports additional positive phase 1 clinical data for Oms824 for the treatment of cognitive disorders
Reuters
Tue, 02/11/14 - 10:38 am
Omeros
OMS824
cognitive disorders
Positive Data on Omeros' OMS824
Yahoo/Zacks.com
Fri, 01/31/14 - 08:07 am
Omeros
OMS824
schizophrenia
2014 FDA Drug Approval Decision Calendar
TheStreet.com
Wed, 11/27/13 - 08:39 am
FDA
drug approvals
GSK
Gilead
Theravance
Auxilium
Amarin
Bristol-Myers Squibb
Biogen Idec
Pozen
Vanda
Chelsea Therapeutics
pSivida
Alimera
United Therapeutics
Biomarin
JNJ
Pharmacyclics
Celgene
MannKind
Santarus
AstraZeneca
Durata Therapeutics
Eli Lilly
Omeros
BioDelivery Sciences
Anacor
Keryx
Cubist Pharmaceuticals
Nektar
Omeros' OMS721 shows positive Phase 1 clinical trial results
Yahoo/Fly on the Wall
Thu, 11/7/13 - 09:48 am
Omeros
OMS721
Omeros gets approval to study eye surgery drug in children; could extend marketing exclusivity
Yahoo/AP
Tue, 10/15/13 - 11:36 am
Omeros
eye surgery
OMS302
What's Moving These 3 Biotechs?
Motley Fool
Fri, 10/4/13 - 12:16 pm
Ligand
Pfizer
Vivus
Omeros

Pages